With a robust background in technology and healthcare investments, the fund manager has successfully executed over 30 deals across North America and Europe. Their strategic style is characterized by a data-driven approach, ensuring rigorous analysis and targeted thematic investments. The manager has achieved notable exits, including a high-profile sale in the biotech sector, demonstrating a keen ability to identify and maximize growth opportunities. Committed to the operator-first philosophy, they leverage extensive industry expertise to guide portfolio companies through all stages of development.